Lack of sinus rhythm predicts readmission, not Beta blockade.
McCulloch
Andrew C
AC
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001578:Benzopyrans / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D000068577:Nebivolol; D010359:Patient Readmission / Q000706:statistics & numerical data*; D010975:Platelet Aggregation Inhibitors; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D010975:Platelet Aggregation Inhibitors; D000068577:Nebivolol